0113 203 7111       07801 443247



  1. Watson J, Back D, Toner P, Lloyd C, Day E, Brady L-M, et al. A randomised controlled feasibility trial of family and social network intervention for young people who misuse alcohol and drugs: study protocol (Y-SBNT). Pilot and Feasibility Studies. 2015;1(1):8.
  2. Rizan C, Ansell J, Wall P, Cocks K, Torkington J. Surgical Smoke During Laparoscopic Surgery: The Effect of Experience. Br J Surg. 2015;102:270-1.
  3. Moverley A, Coates L, Marzo-Ortega H, Waxman R, Torgerson D, Cocks K, et al. A feasibility study for a randomised controlled trial of treatment withdrawal in psoriatic arthritis (REmoval of treatment for patients in REmission in psoriatic ArThritis (RETREAT (F)). Clin Rheumatol. 2015.
  4. Kingsbury SR, Tharmanathan P, Arden NK, Batley M, Birrell F, Cocks K, et al. Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial. Trials. 2015;16:77.
  5. Smith AB, Taylor M, Cocks K, Parry D. A Reliability Generalisation of the Eortc Qlq-Br23. Value Health. 2014;17(7):A571-A.
  6. Smith AB, Cocks K, Taylor M, Parry D. Most domains of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 are reliable. J Clin Epidemiol. 2014;67(8):952-7.
  7. Smith AB, Cocks K, Parry D, Taylor M. Reporting of health-related quality of life (HRQOL) data in oncology trials: A comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G). Apr 2014. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation. 2014;.23(3):pp.
  8. Smith A, Cocks K. Content validity and legacy patient-reported outcome measures in cancer. Qual Life Res. 2014:1-2.
  9. Sheard L, O’Hara J, Armitage G, Wright J, Cocks K, McEachan R, et al. Evaluating the PRASE patient safety intervention – a multi-centre, cluster trial with a qualitative process evaluation: study protocol for a randomised controlled trial. Trials. 2014;15(1):420.
  10. Hicks K, Cocks K, Corbacho Martin B, Elton P, MacNab A, Colecliffe W, et al. An intervention to reassure patients about test results in rapid access chest pain clinic: a pilot randomised controlled trial. BMC Cardiovasc Disord. 2014;14(1):138.
  11. Efficace F, Baccarani M, Breccia M, Saussele S, Abel G, Caocci G, et al. International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: The EORTC QLQ-CML24. Apr 2014. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation. 2014;.23(3):pp.
  12. Cocks K, Velikova G, King MT, Fayers PM, Brown JM. Can individual patients assess differences in quality of life between groups of patients? European Journal of Cancer Care. 2014;.23(2):pp.
  13. James Ansell, Neil Warren, Pete Wall, Kim Cocks, Stuart Goddard, Richard Whiston, Michael Stechman, David Scott-Coombes, Jared Torkington: Electrostatic precipitation is a novel way of maintaining visual field clarity during laparoscopic surgery: a prospective double-blind randomized controlled pilot study. Surgical Endoscopy 02/2014;
  14. Adam B Smith, Kim Cocks, David Parry, Matthew Taylor: Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G).. Quality of Life Research 10/2013;
  15. Cocks K, Torgerson D. Sample size calculations for pilot randomised trials: a confidence interval approach. Journal of Clinical Epidemiology, Volume 66, Issue 2, Feb 2013, p197-201
  16. Efficace F, Breccia M, Saussele S, Kossak U, Cardoni A, Caocci G, Chie W, Naeem A, Nicolatou-Galitis O, Cocks K, Vignetti M, Baccarani M, Mandelli F, Sprangers M. Which Health-Related Quality of Life Aspects are important to patients with Chronic Myeloid Leukemia Receiving Targeted Therapies and to Health Care Professionals? An International Study on behalf of GIMEMA and EORTC Quality of Life Group. Annals of Hematology. Accepted March 2012.
  17. S. Sondergaard, P. Wall, K. Cocks, W. G. Parkin, and M. S. Leaning. High concordance between expert anaesthetists’ actions and advice of decision support system in achieving oxygen delivery targets in high-risk surgery patients. British Journal of Anaesthesia. BJA Advance Access published March 16, 2012
  18. K. Cocks, M. T. King, G. Velikova, G. de Castro Jr., M. Martyn St-James, P. M. Fayers, J. M. Brown on behalf of the EBIG collaborative group. Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer quality of life questionnaire core 30. European Journal of Cancer, Volume 48, Issue 11, July 2012, p1713-1721.
  19. Monica Else, Kim Cocks, Shirley Crofts, Rachel Wade, Sue M. Richards, Daniel Catovsky1, Alastair G. Smith For The UK National Cancer Research Institute (NCRI) Chronic Lymphocytic Leukaemia Trials Group. Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial. Leukemia and Lymphoma; Published ahead of print online 15 Dec 11.
  20. Morgan GJ, Child JA, Gregory WM, Szubert AJ, Cocks K, Bell SE, Navarro-Coy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross FM, Byrne J, Roddie H, Rudin C, Cook G, Jackson GH, Wu P, Davies FE; on behalf of the National Cancer Research Institute Haematological Oncology Clinical Studies Group. Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial. Lancet Oncol. 2011 Aug;12(8):743-752. Epub 2011 Jul 21.
  21. F. Efficace, K. Cocks, M. Breccia, M. Sprangers, C.A. Meyers, M. Vignetti, M. Baccarani, F. Mandelli and GIMEMA and EORTC Quality of Life Group. Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: Inclusion of quality of life and other patient-reported outcomes. Review Article
    Critical Reviews in Oncology/Hematology, In Press, Corrected Proof, Available online 24 March 2011
  22. Hillmen P, Cohen DR, Cocks K, Pettitt A, Sayala HA, Rawstron AC, Kennedy DB, Fegan C, Milligan DW, Radford J, Mercieca J, Dearden C, Ezekwisili R, Smith AF, Brown J, Booth GA, Varghese AM, Pocock C; NCRI CLL Sub-Group. A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. Br J Haematol. 2011 Mar;152(5):570-8. doi: 10.1111/j.1365-2141.2010.08317.x. Epub 2011 Jan 14.
  23. Cocks K. King MT. Velikova G. Martyn St-James M. Fayers PM. Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. [Review] Journal of Clinical Oncology. 29(1):89-96, 2011 Jan 1.
  24. Morgan GJ. Davies FE. Gregory WM. Cocks K. Bell SE. Szubert AJ. Navarro-Coy N. Drayson MT. Owen RG. Feyler S. Ashcroft AJ. Ross F. Byrne J. Roddie H. Rudin C. Cook G. Jackson GH. Child JA. National Cancer Research Institute Haematological Oncology Clinical Study Group. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet. 376(9757):1989-99, 2010 Dec 11.
  25. Velikova G. Keding A. Harley C. Cocks K. Booth L. Smith AB. Wright P. Selby PJ. Brown JM. Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial. European Journal of Cancer. 46(13):2381-8, 2010 Sep.
  26. David C. Johnson, Sophie Corthals, Christine Ramos, Antje Hoering, Kim Cocks, Nicholas J. Dickens, Jeff Haessler, Harmut Goldschmidt, J. Anthony Child, Sue E. Bell, Graham Jackson, Dalsu Baris, S. Vincent Rajkumar, Faith E. Davies, Brian G. M. Durie, John Crowley, Pieter Sonneveld, Brian Van Ness, and Gareth J. Morgan. Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping. Blood, Dec 2008; 112: 4924 – 4934
  27. Monica Else, Alastair G. Smith, Kim Cocks, Sue M. Richards, Shirley Crofts, Rachel Wade, Daniel Catovsky. Patients’ experience of chronic lymphocytic leukaemia: baseline health-related quality of life results from the LRF CLL4 trial. British Journal of Haematology, Volume 143, Issue 5, Dec 2008: 690-697
  28. Kim Cocks, Madeleine T King, Galina Velikova, Peter M Fayers, Julia M Brown. Quality, interpretation and presentation of EORTC QLQ-C30 data in randomised controlled trials. European Journal of Cancer 2008; Volume 44, Issue 13:1793-1798
  29. Vasudev NS, Brown JE, Brown SR, Rafiq R, Morgan R, Patel PM, O’Donnell D, Harnden P, Rogers M, Cocks K, Anderson K, Paul A, Eardley I, Selby PJ and Banks RE. Prognostic Factors in Renal Cell Carcinoma: Association of Pre-Operative Sodium Concentration with Survival. Clinical Cancer Research; 14 (6): 1775-81, 2008 Mar
  30. Cocks K. Cohen D. Wisloff F. Sezer O. Lee S. Hippe E. Gimsing P. Turesson I. Hajek R. Smith A. Graham L. Phillips A. Stead M. Velikova G. Brown J. EORTC Quality of Life Group. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. European Journal of Cancer. 43(11):1670-8, 2007 Jul.
  31. Feyler S. Rawstron A. Jackson G. Snowden JA. Cocks K. Johnson RJ. Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study. British Journal of Haematology. 139(3):429-33, 2007 Nov.
  32. Briggs, M.; Bennett M.I.; Closs, S.J; Cocks K. Painful leg ulceration: a prospective, longitudinal cohort study. Wound Repair and Regeneration. 15:186-191, 2007.
  33. Durie BG. Harousseau JL. Miguel JS. et al on behalf of the International Myeloma Working Group. International uniform response criteria for multiple myeloma. Leukemia. 20(9):1467-73, 2006 Sep
  34. Amniocentesis results: investigation of anxiety. The ARIA trial. J Hewison, J Nixon, J Fountain, K Cocks, C Jones, G Mason, S Morley, J Thornton. Health Technology Assessment.2006; Vol 10: No. 50
  35. Goodyear PW. Raine CH. Firth AL. Tucker AG. Hawkins K. The Bradford bone-anchored hearing aid programme: impact of the multidisciplinary team. [Journal Article] Journal of Laryngology & Otology. 120(7):543-52, 2006 Jul.
  36. Pressure RElieving Support SUrfaces: a Randomised Evaluation. J Nixon, EA Nelson, G Cranny, CP Iglesias, K Hawkins, NA Cullum, A Phillips, K Spilsbury, DJ Torgerson and S Mason on behalf of the PRESSURE Trial Group. Health Technology Assessment.2006; Vol 10: No 22.
  37. Nixon J. Cranny G. Iglesias C. Nelson EA. Hawkins K. Phillips A. Torgerson D. Mason S. Cullum N. Randomised, controlled trial of alternating pressure mattresses compared with alternating pressure overlays for the prevention of pressure ulcers: PRESSURE (pressure relieving support surfaces) trial.[see comment]. [Journal Article. Multicenter Study. Randomized Controlled Trial] BMJ. 332(7555):1413, 2006 Jun 17.
  38. Iglesias C. Nixon J. Cranny G. Nelson EA. Hawkins K. Phillips A. Torgerson D. Mason S. Cullum N. PRESSURE Trial Group. Pressure relieving support surfaces (PRESSURE) trial: cost effectiveness analysis.[see comment]. [Journal Article. Multicenter Study. Randomized Controlled Trial] BMJ. 332(7555):1416, 2006 Jun 17.
  39. S Brown, H Thorpe, K Hawkins, J Brown. Minimisation – Reducing predictability for multi-centre trials whilst retaining balance within centre. Statistics in medicine 2005;24:3715-3727
  40. D.J.Dodwell, K Dyker, J Brown, D Cohen, K Hawkins, M Stead, D Ash. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clinical Oncology. 17(8):618-22, 2005 Dec.
  41. Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brown J, Drayson MT, Selby PS, for the Medical Research Council Adult Leukaemia Working Party. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. New England Journal of Medicine 2003; 348: 1875-1883.
  42. R O’Leary, K Hawkins, JCS Beazley, MRJ Lansdown, AM Hanby. Agreement between preoperative core needle biopsy and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained. Journal of Clinical Pathology 2003; 57:193-195.
  43. Watson SA. Morris TM. Collins HM. Bawden LJ. Hawkins K. Bone EA. Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA. British Journal of Cancer, 1999, Sep;81(1):19-23.
  44. Bernstein SH. Eaves CJ. Herzig R. Fay J. Lynch J. Phillips GL. Christiansen N. Reece D. Ericson S. Stephan M. Kovalsky M. Hawkins K. Rasmussen H. Devos A. Herzig GP. A randomised phase II study of BB-10010; a variant of human macrophage inflammatory protein-1 alpha for patients receiving high dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer. British Journal of Haematology, 1997, Dec 99:888-895.